BPC-157 drives localized collagen synthesis and tendon-to-bone healing
Neurotrophic support during healing phase
These are typically administered either intramuscularly (IM) or intravenously (IV), depending on the product and the individuals needs
NICE-aligned management typically involves: Addressing modifiable risk factors (smoking cessation, weight loss, increased physical activity, alcohol reduction) Optimising management of underlying conditions (diabetes, hypertension, depression) Trial of PDE5 inhibitor therapy Referral to specialist services (urology/andrology) if first-line treatments fail or where structural/neurological/endocrine causes are suspected Consideration of psychosexual therapy where appropriate Men should be reassured that ED is a medical condition with effective treatments, and seeking help through proper channels ensures safety, appropriate investigation of underlying causes, and access to evidence-based therapies
Lower-Risk Editorial Cover Design A BPC-157 cover should communicate scientific identity without suggesting a consumer benefit, clinical endorsement or route to use
These are foundational practices that everyone should consider
